Juris J Liepnieks1, Lucy Q Zhang, Merrill D Benson. 1. Indiana University School of Medicine, Department of Pathology and Laboratory Medicine, 635 Barnhill Drive, Indianapolis, IN 46202-5126, USA. mdbenson@iupui.edu
Abstract
OBJECTIVE: To biochemically characterize peripheral nerve amyloid in subjects with transthyretin (TTR) amyloidosis and assess effect of orthotopic liver transplantation (OLT) on progression of neuropathy. METHODS: Amyloid fibrils were isolated from peripheral nerve tissues of 6 patients with TTR amyloidosis who were heterozygous for an amyloid-associated TTR mutation. Ratio of variant to wild-type TTR in the fibrils was determined by amino acid sequencing of tryptic peptides containing either the variant amino acid residue or the corresponding normal amino acid. RESULTS: Amyloid fibrils from 3 subjects who died without having received a liver transplant were composed of 60%-65% variant TTR and 35%-40% wild-type. Amyloid fibrils from a subject who died 5 years after liver transplantation contained 25% variant and 75% wild-type TTR. CONCLUSION: Ratios of variant to wild-type TTR in amyloid patients heterozygous for an amyloid-associated TTR mutation are similar to published ratios for amyloid fibrils in cardiac tissue. Survival after liver transplantation for TTR amyloidosis may be associated with progression of neuropathy due to continued deposition of amyloid derived from wild-type TTR.
OBJECTIVE: To biochemically characterize peripheral nerve amyloid in subjects with transthyretin (TTR) amyloidosis and assess effect of orthotopic liver transplantation (OLT) on progression of neuropathy. METHODS: Amyloid fibrils were isolated from peripheral nerve tissues of 6 patients with TTRamyloidosis who were heterozygous for an amyloid-associated TTR mutation. Ratio of variant to wild-type TTR in the fibrils was determined by amino acid sequencing of tryptic peptides containing either the variant amino acid residue or the corresponding normal amino acid. RESULTS: Amyloid fibrils from 3 subjects who died without having received a liver transplant were composed of 60%-65% variant TTR and 35%-40% wild-type. Amyloid fibrils from a subject who died 5 years after liver transplantation contained 25% variant and 75% wild-type TTR. CONCLUSION: Ratios of variant to wild-type TTR in amyloid patients heterozygous for an amyloid-associated TTR mutation are similar to published ratios for amyloid fibrils in cardiac tissue. Survival after liver transplantation for TTRamyloidosis may be associated with progression of neuropathy due to continued deposition of amyloid derived from wild-type TTR.
Authors: M Yazaki; S Mitsuhashi; T Tokuda; F Kametani; Y-I Takei; J Koyama; A Kawamorita; H Kanno; S-I Ikeda Journal: Am J Transplant Date: 2006-10-25 Impact factor: 8.086
Authors: E A Pomfret; W D Lewis; R L Jenkins; P Bergethon; S W Dubrey; J Reisinger; R H Falk; M Skinner Journal: Transplantation Date: 1998-04-15 Impact factor: 4.939
Authors: A J Stangou; P N Hawkins; N D Heaton; M Rela; M Monaghan; P Nihoyannopoulos; J O'Grady; M B Pepys; R Williams Journal: Transplantation Date: 1998-07-27 Impact factor: 4.939
Authors: M Ankarcrona; B Winblad; C Monteiro; C Fearns; E T Powers; J Johansson; G T Westermark; J Presto; B-G Ericzon; J W Kelly Journal: J Intern Med Date: 2016-05-10 Impact factor: 8.989
Authors: Adam J Loavenbruck; Vinay Chaudhry; Steven R Zeldenrust; Robert J Spinner; Jason D Theis; Christopher J Klein Journal: Muscle Nerve Date: 2012-11 Impact factor: 3.217
Authors: John L Berk; Ole B Suhr; Laura Obici; Yoshiki Sekijima; Steven R Zeldenrust; Taro Yamashita; Michael A Heneghan; Peter D Gorevic; William J Litchy; Janice F Wiesman; Erik Nordh; Manuel Corato; Alessandro Lozza; Andrea Cortese; Jessica Robinson-Papp; Theodore Colton; Denis V Rybin; Alice B Bisbee; Yukio Ando; Shu-ichi Ikeda; David C Seldin; Giampaolo Merlini; Martha Skinner; Jeffery W Kelly; Peter J Dyck Journal: JAMA Date: 2013-12-25 Impact factor: 56.272